2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)Multi Vessel Coronary Artery DiseaseEnrolling by invitationNot applicable2026-07-29NCT04545112
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)Chronic Coronary Syndrome; Stable Coronary Artery Disease CADRecruitingPhase 32026-07-14NCT07195149